| 1.1 |
9.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.7 |
4.3 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.6 |
1.8 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) phosphate ion transmembrane transport(GO:0035435) |
| 0.5 |
2.6 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.5 |
1.4 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.5 |
1.4 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.4 |
1.8 |
GO:2000551 |
regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.4 |
1.2 |
GO:0007521 |
muscle cell fate determination(GO:0007521) mammary placode formation(GO:0060596) |
| 0.4 |
1.5 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.4 |
1.9 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.4 |
1.9 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.4 |
1.1 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.4 |
2.2 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) |
| 0.4 |
1.8 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.4 |
1.4 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.3 |
2.7 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.3 |
0.7 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.3 |
1.9 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.3 |
1.2 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.3 |
0.9 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.3 |
1.1 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.3 |
1.1 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.3 |
0.8 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.3 |
1.3 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.2 |
0.7 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.2 |
2.3 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.2 |
4.0 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.2 |
1.1 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.2 |
1.3 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.2 |
0.9 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.2 |
0.6 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.2 |
1.0 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.2 |
1.2 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.2 |
0.8 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.2 |
1.2 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.2 |
0.6 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.2 |
1.1 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.2 |
0.5 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.2 |
0.5 |
GO:0060126 |
somatotropin secreting cell differentiation(GO:0060126) |
| 0.2 |
0.5 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.2 |
0.5 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.2 |
0.8 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.2 |
0.6 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.1 |
0.4 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.1 |
0.6 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) cardiac cell fate specification(GO:0060912) |
| 0.1 |
2.4 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.1 |
1.0 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 |
1.2 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.1 |
3.9 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.1 |
0.4 |
GO:0010986 |
complement receptor mediated signaling pathway(GO:0002430) GPI anchor release(GO:0006507) positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.1 |
0.7 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.1 |
1.2 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 |
0.4 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 |
0.6 |
GO:0070171 |
negative regulation of tooth mineralization(GO:0070171) |
| 0.1 |
0.6 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.1 |
0.5 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 |
2.9 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
0.3 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.1 |
1.0 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
1.4 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 0.1 |
1.2 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.1 |
0.7 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.1 |
0.6 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
0.6 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 |
0.2 |
GO:0032714 |
negative regulation of interleukin-5 production(GO:0032714) |
| 0.1 |
0.7 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 |
1.9 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.1 |
0.8 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.1 |
0.3 |
GO:0010648 |
negative regulation of cell communication(GO:0010648) |
| 0.1 |
1.7 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
1.0 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.1 |
0.2 |
GO:0050787 |
glycolate metabolic process(GO:0009441) enzyme active site formation via L-cysteine sulfinic acid(GO:0018323) primary alcohol biosynthetic process(GO:0034309) cellular response to glyoxal(GO:0036471) glycolate biosynthetic process(GO:0046295) detoxification of mercury ion(GO:0050787) negative regulation of TRAIL-activated apoptotic signaling pathway(GO:1903122) regulation of pyrroline-5-carboxylate reductase activity(GO:1903167) positive regulation of pyrroline-5-carboxylate reductase activity(GO:1903168) regulation of tyrosine 3-monooxygenase activity(GO:1903176) positive regulation of tyrosine 3-monooxygenase activity(GO:1903178) L-dopa metabolic process(GO:1903184) L-dopa biosynthetic process(GO:1903185) glyoxal metabolic process(GO:1903189) glyoxal catabolic process(GO:1903190) regulation of L-dopa biosynthetic process(GO:1903195) positive regulation of L-dopa biosynthetic process(GO:1903197) regulation of L-dopa decarboxylase activity(GO:1903198) positive regulation of L-dopa decarboxylase activity(GO:1903200) positive regulation of cellular amino acid biosynthetic process(GO:2000284) positive regulation of androgen receptor activity(GO:2000825) |
| 0.1 |
0.8 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.6 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.1 |
0.6 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
0.6 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.1 |
0.2 |
GO:0001907 |
killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.1 |
1.1 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.1 |
0.4 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.1 |
0.6 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 |
0.9 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 |
0.4 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.5 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.1 |
1.0 |
GO:0001504 |
neurotransmitter uptake(GO:0001504) |
| 0.1 |
0.6 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.8 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.5 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.5 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.0 |
0.4 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.6 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.0 |
0.1 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 |
0.1 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 |
2.6 |
GO:0035383 |
acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
| 0.0 |
0.2 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.0 |
0.4 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
| 0.0 |
0.4 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 |
0.6 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.0 |
0.1 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 |
0.6 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 |
2.0 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.0 |
1.4 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 |
1.1 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.0 |
1.5 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.0 |
0.7 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.0 |
0.1 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.3 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.0 |
0.4 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 |
0.4 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
2.2 |
GO:0010950 |
positive regulation of endopeptidase activity(GO:0010950) |
| 0.0 |
0.1 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.0 |
0.4 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.2 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 |
0.1 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.2 |
GO:0048246 |
macrophage chemotaxis(GO:0048246) |
| 0.0 |
1.0 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.1 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.5 |
GO:1902108 |
regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
| 0.0 |
0.2 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 |
0.9 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
| 0.0 |
0.7 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.6 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
0.4 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.0 |
2.4 |
GO:0021915 |
neural tube development(GO:0021915) |
| 0.0 |
1.1 |
GO:1903749 |
positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
0.9 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.3 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.0 |
0.9 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) |
| 0.0 |
0.4 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 |
1.1 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 |
0.3 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
1.6 |
GO:0007219 |
Notch signaling pathway(GO:0007219) |
| 0.0 |
0.4 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
